The Role of Mineralocorticoid Receptors in Vascular Function

NCT00759525 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Apparent Mineralocorticoid Excess (AME)

Interventions

DRUG: Glycyrrhetic Acid
DRUG: Placebo

Sponsor

Brigham and Women's Hospital